Value in Health

Contributed Podium Presentations
pp. A1-A21(21)

Contributed Poster Presentations
pp. A22-A194(173)

HEALTH CARE DECISIONS USING OUTCOMES RESEARCH CASE STUDY PRESENTATIONS

DISCLOSURE INFORMATION
pp. A208-A213(6)

Abstracts Index
pp. A214-A220(7)

A Cost-Effectiveness Decision Model for Antiepileptic Drug Treatment in Newly Diagnosed Epilepsy Patients
pp. 173-182(10)
Authors: Knoester, Pieter D.; Deckers, Charles L. P.; Termeer, Eveline H.; Boendermaker, Arjo J.; Kotsopoulos, Irene A. W.; de Krom, Marc C. T. F. M.; Keyser, Toine; Renier, Willy O.; Hekster, Yechiel A.; Severens, Hans L.

A Systematic Review Evaluating Health-Related Quality of Life, Work Impairment, and Health-Care Costs and Utilization in Abnormal Uterine Bleeding
pp. 183-194(12)
Authors: Liu, Zhimei; Doan, Quan V.; Blumenthal, Paul; Dubois, Robert W.

Eliciting Expert Opinion for Economic Models: An Applied Example
pp. 195-203(9)
Authors: Leal, José; Wordsworth, Sarah; Legood, Rosa; Blair, Edward

Estimating the Rate of Accumulating Drug Resistance Mutations in the HIV Genome
pp. 204-213(10)
Authors: Braithwaite, R. Scott; Shechter, Steven; Chang, Chung-Chou H.; Schaefer, Andrew; Roberts, Mark S.

Mapping from Disease-Specific Measures to Utility: An Analysis of the Relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's Disease and Measures of Utility
pp. 214-220(7)
Authors: Buxton, Martin J.; Lacey, Loretto A.; Feagan, Brian G.; Niecko, Timothy; Miller, David W.; Townsend, Raymond J.

Substantial Treatment Overuse in the United States?
pp. 221-221(1)
Author: Gandjour, Afschin

Substantial Treatment Overuse in the United States?—Response to Grandjour
pp. 222-222(1)
Author: Luce, Bryan R.